Reine Allan
SEC insider (Form 3/4/5 filer). CIK 0001714023. Chief Executive Officer at Prime Medicine, Inc. (PRME). 8 reported Form 4/5 transactions since Sep 2024; latest on Feb 26, 2026. Located in CAMBRIDGE, MA.
Companies Reine Allan has filed insider reports for
- Prime Medicine, Inc. (PRME): Director, Officer, Chief Executive Officer
Reine Allan
CIK: 0001714023
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Prime Medicine, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Feb 26, 2026PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
1.3M shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
DispositionDirectStock Option (right to buy)
850K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
850K shares- - May 21, 2025PRME
Prime Medicine, Inc.
PurchaseDirect125K shares at avg. $1.18$147K - May 19, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
2M shares- - May 8, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
75K shares- - Feb 27, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
275K shares- - Dec 5, 2024PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
75K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 26, 2026 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 1,300,000 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Disposition Stock Option (right to buy) | 850,000 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 850,000 | - | - | Direct |
| May 21, 2025 | PRME Prime Medicine, Inc. | Purchase | 125,000 | $1.18 | $147,150 | Direct |
| May 19, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 2,000,000 | - | - | Direct |
| May 8, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 75,000 | - | - | Direct |
| Feb 27, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 275,000 | - | - | Direct |
| Dec 5, 2024 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 75,000 | - | - | Direct |
1-8 of 8 transactions